{"name":"Servier Russia","slug":"servier-russia","ticker":"","exchange":"","domain":"servierrussia.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1980-01-01","label":"Detralex first approved","drug":"Detralex","drugSlug":"detralex","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Detralex","genericName":"Detralex","slug":"detralex","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Detralex","genericName":"Detralex","slug":"detralex","phase":"marketed","mechanism":"Detralex works by enhancing venous tone and microcirculation through the action of diosmin and hesperidin.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNWmYtU3dxOVd2MGRMdGJtWU55bXc2cnVsSDkzVFFKMHZlQlBLWXFMa3FqZWxYb2RITGRsZ19zRlVlZDN0Sy14dDdDV1IwTW9uVWY0TkU0bDIzTGxQYks4ZW13Njc4LUpsb2IxY1dYR2tZcDFIQnZVaWFTOWt5a0F6QmwyM2NidHlFWkIxbG0tSkkxM2FFb21WQlhYU0VHSV9LeVVxRnRhMVB1N3poQ0poMVNIUS1mcnNiOUN4RmlrWDAzMHV5Y1ZwY09QQkl5akVzZ2JnUw?oc=5","date":"2026-04-08","type":"pipeline","source":"Egyptian Gazette","summary":"Health Ministry, Servier explore avenues of localising pharma industry in oncology, innovative therapies - Egyptian Gazette","headline":"Health Ministry, Servier explore avenues of localising pharma industry in oncology, innovative therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQNU5vVjRXenJxb1V4Y0hyRUlPZE9WRkhUTUpWWVRrNk0wSVNmWU95dGRlMWVVZVVWYTV0Q3JGNzhNU2xaQmVlUGd6clRpYlZNRXpXZVAxQnNOQ19aRk9xQmRBelRRcld4eEluVmpSYWNUZTd4MjV3ZFllNTROUmhEMUlmdFlZbTYtSGZTZjE2MXRBVEpiYmpsNVFmd0tNdldhLXRHekhoTmVqbHNIdDdoLWFDRlp4WTh6YzhnTQ?oc=5","date":"2026-01-14","type":"pipeline","source":"The Pharma Letter","summary":"Russia to focus on more active import substitution in domestic pharma sector - The Pharma Letter","headline":"Russia to focus on more active import substitution in domestic pharma sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZnZXRTZ0VHRfQkppUzBET1AwX3ZQUlVVZExGcGtXV0d0dXNmNUFRVW5LaFdzeDR4RGpxZGgtWUQwYjROcXQ1LXpCX09tMGhiWkxCNFJ2X2ZxamhteWhtUFBneU9SQ3RObXVlNUJLRmdVbWlEMlRQb1JyOGJvZVNkRndrZ0Z2MDR2eFVySnU0UjJObTgtVEJwdWg1YjJqY3ppRUhjdmlVaE0?oc=5","date":"2025-12-30","type":"pipeline","source":"The Pharma Letter","summary":"Global drugmakers lose legal battles in Russian pharma market - The Pharma Letter","headline":"Global drugmakers lose legal battles in Russian pharma market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQV1p6QzE3TTF6YXFMQm9PMF9nWW1QNFEta0k2ajd6VHlqMHpvSWt2OHpzanNmVWh0enlVbHVkOXhvRUxpckF2X0QwcjI3V3FuZDFnc1c1aUo2ZTJBeE9jRmVsd1d5ZmVyX3dtWXN5ZFpGRlJWVTVxWTVOSE9CTkdyczUxaDN4QzM3S1IxSFY0TGk5SlBQdkloLXpjVnpDek50OVRKRXZiMnZ1VjhTdGZpUg?oc=5","date":"2025-12-29","type":"pipeline","source":"The Pharma Letter","summary":"Russia to sharply reduce share of imported drugs in domestic market - The Pharma Letter","headline":"Russia to sharply reduce share of imported drugs in domestic market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE1UdHczTEY5bkMyWUhxbHpwMUV1WXVwYmFTSV9WckpndllYQ0duWWZsRFNDajcwWEJnQmRsOXlfcVJVWHBZc3VKSDJaRXdWelVQLWdMaQ?oc=5","date":"2025-10-24","type":"pipeline","source":"Официальный сайт Мэра Москвы","summary":"Moscow companies increase production of pharmaceuticals / News / Moscow City Web Site - Официальный сайт Мэра Москвы","headline":"Moscow companies increase production of pharmaceuticals / News / Moscow City Web Site - Официальный сайт Мэра Москвы","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNbUczMEw4S2Z3SElKR3RMVGU2Q2YyTHRpSnJaUWxvSXR4MUI5clpMYlNpTHNrcFRTSjc1SFRvR3BYcU5ZcFVmSjFsR1Vkckcyd09FcWxLbkJtRTlpNWc4QngzZ21PV3JGckljUE1MSERwTFlMUlJkbm9zYURsWWttbi11eGxrY3R3LWdfVlY0SUpLNWFMdkNaTkJmSHBpbkJESEtiNmlReTczaExjamRR?oc=5","date":"2025-08-04","type":"pipeline","source":"RFI","summary":"Biogaran sale talks renew fears over foreign control of French pharma - RFI","headline":"Biogaran sale talks renew fears over foreign control of French pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNUFJoNEdZdlRXSnpMdTJSaUJSVTcteVBDUXFRNVM4NUtyd0JBbUk5aDNmMFVrdmtnS0hxVkZiUHhvTHZSVWpZMW1pLU8wWU03S29rWFBmZml1anZKQzZHbVd3QThjVmFZRXdIY05kbmdESUsza21NdmQtTUNLYmVmcXBvZmhsN0l6amfSAYoBQVVfeXFMTVBSaDRHWXZUV0p6THUyUmlCUlU3LXlQQ1FxUTVTODVLcndCQW1JOWgzZjBVa3ZrZ0tIcVZGYlB4b0x2UlVqWTFtaS1PMFlNN0tva1hQZmZpdWp2SkM2R21Xd0E4Y1ZhWUV3SGNOZG5nRElLM2ttTXZkLU1DS2JlZnFwb2ZobDdJempn?oc=5","date":"2025-07-31","type":"regulatory","source":"Новости GxP","summary":"Anti-anxiety drugs remain in demand among Russians - Новости GxP","headline":"Anti-anxiety drugs remain in demand among Russians - Новости GxP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQSzBEZjlrWEx3QVJfT3NFbnhQY256Uzd0SVNSdXduOTYtc2FKcmFtaDBLUkhoZjY1b3NYSXFVTjBqeVd0ell5VjJTLUx6aGQxQTlXZnFveXJpWi1XZnVDeU9oRG9YNU5QTDF1eTVfS1Rhc05VdTJhODRPNGsxUWFhQzdqNGNsVFkzLVQ0UEZHcTFRRHVFZXJka01JWQ?oc=5","date":"2024-07-12","type":"pipeline","source":"Dechert","summary":"The Servier Case: The Game isn’t Over Yet - Dechert","headline":"The Servier Case: The Game isn’t Over Yet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOdDZKQUZXU2FyX1BNRlpvbk1xcUhxeE1ka1dIbDlGU25IRmlSdnd0NjJrdTJKX3RUbnQ1MGlTakN4OGtfVHpoZjRsQUJXRXBacmdBU3pxUmp5NzZMeHlOYjNBenZpRGFYQnNYQXFkNnpfanVhaUxQc2VSbmJqZFZDcmQtN2ZxODd4cXd4bTVheTFwZTU3TWV0RzhwbmlKSV9uYnV1eU1ob2xqeU0wcHNmSHI3WnJHUDhNdzI4Y3dxZDJLdHR2NzJOSmJoVWZESEVqSnR1S1VyYzRZRmFuSnlHSFZPbV8?oc=5","date":"2023-12-20","type":"pipeline","source":"Le Monde.fr","summary":"Pharma firm Servier ordered to pay millions over deadly Mediator drug - Le Monde.fr","headline":"Pharma firm Servier ordered to pay millions over deadly Mediator drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOQzdsa3JFR3lWVXBycFRpdlMteFRBU2gyQ2VTOG5iUmh5M2dHMTBzcVlwdUhsaEhaNTRKMjRpN2NTZnFnaUxEZ3g3Z0JyVUx1NGdGR2JaXzdfZUNRbjlBb2tyN0pUaW5fTWlSZnZORHVIY0Y3MUE0V0RWem9OaEZWeEhmMklDNVNqSXdB?oc=5","date":"2022-07-04","type":"pipeline","source":"Pharmaceutical Technology","summary":"Russia’s focus on domestic pharma production could shield it from sanctions’ effects - Pharmaceutical Technology","headline":"Russia’s focus on domestic pharma production could shield it from sanctions’ effects","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE1HYkQxaERFNUNZOWZMUHlNWWp2dm9YWHdPZDFydFU3YnFmeXBCNURlay02SWd4TlVPaWZwRGEzTlpQWUl2aTkySHEwaFRRWW9JcTF6VXpSQ056UWx3VFBZUnoxTXVLRTNxOFp3?oc=5","date":"2020-08-08","type":"pipeline","source":"PharmTech.com","summary":"Servier: patience and passion - PharmTech.com","headline":"Servier: patience and passion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOTWhYT1hMaE9FS241NmlzUUpwRTU3dlhYNVBnLWVjcDhHQ3J2b0tJSHFjMnRENTFvUzFVeUhhRjQ5ZnJ2TmxQV1NIZDNNRjZHNmRERXlVSE15RFJnVTlTbUFsRjFLX2tZSGJaVkQzWXZjbzI1RTI3eE4wZmlrVHcwYkpHR0hJaFhaSWg0U19mcWRYbzA?oc=5","date":"2019-05-09","type":"pipeline","source":"BioPharma Dive","summary":"Servier's US push takes shape as Boston HQ opens - BioPharma Dive","headline":"Servier's US push takes shape as Boston HQ opens","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}